BREAKINGتازہ ترینताज़ा खबर
Ecuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali Headache800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over ProtestTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources Say8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground StopFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpCanberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030El-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesEcuador Fishermen Sue Trump Over US Boat StrikesIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeIsrael Divided Over Possible New Iran StrikeRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackRandy Travis Given 1% Chance Before ComebackFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali HeadacheFitness Coach in ICU With Meningitis After Bali Headache800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over Protest800,000 Young Pakistanis Chose Exit Over ProtestTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources SayTrump May Hold Off Iran Attacks, Sources Say8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop8 College Football Games Moved After Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground Stop6,600 US Flights Cancelled in Nationwide Ground StopFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpFederalist Society Ready to Move On From TrumpCanberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030Canberra Targets 30% More ASEAN Students by 2030El-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesEl-Sayed: Stop Funding Foreign Armies With US TaxesCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentCalifornia Democrats Probe Trump, Hold Off ImpeachmentWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberWindows 11's New Run Box Arrives for All in DecemberRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonRogan: Nunes Has Huge Striking Edge Over HarrisonStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskStatins After 70: Stopping Them Raises Heart RiskNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyNew Congress May Doubt Trump's Tough Cuba PolicyLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaLHC Forms Larger Bench on PTI Symbol PleaNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeNearly $20M Found in Hungary Corruption ProbeCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersCybertruck Fans in Mourning, Demand Musk AnswersColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in UpsetColorado Stuns No. 14 Houston 42-32 in Upset
Advertisement
Text size:
Health • 2026-11-11, 14:10 ET • ~1 min read

Moderna: Cancer Vaccine Could Top Keytruda

Moderna: Cancer Vaccine Could Top Keytruda

Moderna: Cancer Vaccine Could Top Keytruda

Moderna: Cancer Vaccine Could Top Keytruda

Key points

اہم نکات

मुख्य बातें

  • Moderna's personalised cancer vaccine cut the risk of melanoma returning or killing patients by 42%, and its chief executive says it could one day outsell Keytruda, the world's biggest cancer drug.
  • The mRNA vaccine, intismeran, is made for each patient from their own tumour and given alongside Merck's Keytruda; in a Phase III trial of more than 1,100 high-risk melanoma patients it also cut the risk of the cancer spreading by 38%.
  • Chief executive Stephane Bancel told the Financial Times pharma summit on November 10 that the treatment will be tried everywhere Keytruda works, including lung, bladder and pancreatic cancers.
  • Moderna's personalised cancer vaccine cut the risk of melanoma returning or killing patients by 42%, and its chief executive says it could one day outsell Keytruda, the world's biggest cancer drug.
  • The mRNA vaccine, intismeran, is made for each patient from their own tumour and given alongside Merck's Keytruda; in a Phase III trial of more than 1,100 high-risk melanoma patients it also cut the risk of the cancer spreading by 38%.
  • Chief executive Stephane Bancel told the Financial Times pharma summit on November 10 that the treatment will be tried everywhere Keytruda works, including lung, bladder and pancreatic cancers.
  • Moderna's personalised cancer vaccine cut the risk of melanoma returning or killing patients by 42%, and its chief executive says it could one day outsell Keytruda, the world's biggest cancer drug.
  • The mRNA vaccine, intismeran, is made for each patient from their own tumour and given alongside Merck's Keytruda; in a Phase III trial of more than 1,100 high-risk melanoma patients it also cut the risk of the cancer spreading by 38%.
  • Chief executive Stephane Bancel told the Financial Times pharma summit on November 10 that the treatment will be tried everywhere Keytruda works, including lung, bladder and pancreatic cancers.

Moderna's personalised cancer vaccine cut the risk of melanoma returning or killing patients by 42%, and its chief executive says it could one day outsell Keytruda, the world's biggest cancer drug. The mRNA vaccine, intismeran, is made for each patient from their own tumour and given alongside Merck's Keytruda; in a Phase III trial of more than 1,100 high-risk melanoma patients it also cut the risk of the cancer spreading by 38%. Chief executive Stephane Bancel told the Financial Times pharma summit on November 10 that the treatment will be tried everywhere Keytruda works, including lung, bladder and pancreatic cancers. Moderna hopes to launch commercially in 2027 if regulators approve it, after shares in the company rose sharply on the trial results.

Moderna's personalised cancer vaccine cut the risk of melanoma returning or killing patients by 42%, and its chief executive says it could one day outsell Keytruda, the world's biggest cancer drug. The mRNA vaccine, intismeran, is made for each patient from their own tumour and given alongside Merck's Keytruda; in a Phase III trial of more than 1,100 high-risk melanoma patients it also cut the risk of the cancer spreading by 38%. Chief executive Stephane Bancel told the Financial Times pharma summit on November 10 that the treatment will be tried everywhere Keytruda works, including lung, bladder and pancreatic cancers. Moderna hopes to launch commercially in 2027 if regulators approve it, after shares in the company rose sharply on the trial results.

Moderna's personalised cancer vaccine cut the risk of melanoma returning or killing patients by 42%, and its chief executive says it could one day outsell Keytruda, the world's biggest cancer drug. The mRNA vaccine, intismeran, is made for each patient from their own tumour and given alongside Merck's Keytruda; in a Phase III trial of more than 1,100 high-risk melanoma patients it also cut the risk of the cancer spreading by 38%. Chief executive Stephane Bancel told the Financial Times pharma summit on November 10 that the treatment will be tried everywhere Keytruda works, including lung, bladder and pancreatic cancers. Moderna hopes to launch commercially in 2027 if regulators approve it, after shares in the company rose sharply on the trial results.

Most read

سب سے زیادہ پڑھی گئی

सबसे ज़्यादा पढ़ी गई

  1. Loading...
Advertisement